Rhea Fertility has made a strategic move to bolster mental health support within fertility care by acquiring Tilly, a digital fertility health company founded in 2019 by Anna Sane and Jenny Ann Axson Johnson. Tilly specializes in providing evidence-based mental health tools and comprehensive treatment tracking for individuals facing infertility. This acquisition aims to integrate these crucial psychosocial support services into Rhea’s global network of clinics.
Addressing the Emotional Toll of Fertility Treatment
Jenny Ann Axson Johnson, Co-Founder of Tilly, emphasized the emotional challenges that often drive patients to discontinue fertility treatments. She explained, “Research consistently shows that the emotional toll is one of the primary reasons fertility patients discontinue treatment. Our platform removes barriers to accessing proven support, ensuring that patients receive the care they need throughout their journey.”
Tilly has been working with fertility clinics across Europe and the U.S. to provide tailored digital mental health solutions designed specifically for fertility patients. Their services focus on reducing the emotional burden that often accompanies the fertility process, enabling patients to access tools that support their well-being.
Seamless Integration of Mental Health Support
Tilly’s founders, Anna Sane and Jenny Ann Axson Johnson, have seen significant improvements in patient well-being when their mental health tools are integrated directly into the fertility care process. Anna Sane commented, “We have seen the most significant improvements in patient well-being when our tools are seamlessly integrated into the fertility care process. Recognizing the need for greater consolidation in the fertility market, we are thrilled to join Rhea Fertility and contribute to its comprehensive reproductive health ecosystem.”
With this acquisition, Rhea Fertility is aiming to create a more holistic approach to fertility treatment by ensuring that patients receive not only medical care but also robust emotional and mental health support.
Rhea Fertility’s Commitment to Comprehensive Care
Margaret Wang, CEO of Rhea Fertility, expressed her excitement about the acquisition, stating, “We were highly impressed by the platform and content developed by Tilly. As part of our commitment to enhancing the patient experience within our GenPrime clinics, we recognize that psychosocial support is a critical component of the fertility journey.”
This acquisition is part of Rhea Fertility’s broader strategy to enhance its patient care offerings. It follows the company’s recent purchase of Embryonics, an advanced suite of AI-powered diagnostic tools aimed at improving fertility treatment outcomes.
Rhea Fertility, operating a global network of owned and partner clinics under the GenPrime brand, continues to innovate within the reproductive health space. The company is powered by Rhea Labs, a technology-driven platform utilizing data and insights to accelerate innovation and optimize patient outcomes. Through this integration of Tilly’s services, Rhea Fertility aims to offer a more comprehensive and supportive experience for individuals navigating fertility treatments.
